> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Guide on ANDA Meeting Requests
- URL: https://www.fdaweb.com/guide-on-anda-meeting-requests/
- Published: 2024-08-19T12:00:00.000Z
- Updated: 2026-09-14T14:38:48.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5157600

FDA has posted a [final guidance](https://www.fda.gov/media/165468/download?ref=fdaweb.com) entitled “Product-Specific Guidance (PSG) Meetings Between FDA and ANDA Applicants Under GDUFA.” The document provides recommendations on meetings between FDA and a prospective applicant preparing to submit or has already submitted an ANDA. It includes information about requesting and conducting PSG meetings with FDA (i.e., pre- and post-submission PSG teleconferences and meetings. Additionally, it offers procedures that are intended to promote well-managed PSG meetings and help ensure that such meetings are scheduled and conducted in accordance with the time frames outlined in the user fee commitment letter.